Opioid use to relieve pain and suffering at end of life is safe in hospital-at-home setting
According to a study in Journal of Palliative Medicine
2010-09-09
(Press-News.org) New Rochelle, NY, September 9, 2010—Patients who choose to spend their last days at home with specialized care and monitoring can safely be given opioids to control pain and other symptoms without reducing survival time, according to a study published in Journal of Palliative Medicine (JPM), a peer-reviewed journal from Mary Ann Liebert, Inc.(www.liebertpub.com). The article is available free online at www.liebertpub.com/jpm
The use of high-dose opioids to relieve symptoms such as pain and shortness of breath in hospital- or hospice-based end-of-life care is proven to be effective but is available in only a few countries in the world. Many physicians around the world are afraid to prescribe opioids in sufficient doses to be effective in terminally ill patients in the home setting. Consequently, it is important that Itxaso Bengoechea, MD and colleagues from Galdakao-Usánsolo Hospital in Bizkaia, Spain, conducted a retrospective study on the safety and survival effects of increasing doses of opioids during end-of-life care at home. The study included 223 patients with terminal cancer who received specialized medical and nursing care and active monitoring in their homes.
The authors report that opioid use is both safe and effective and, in fact, patients who received a greater than two-fold increase in their initial dose had a longer median survival (22 days) than those who received lower doses (9 days). In the article entitled "Opioid Use at the End of Life and Survival in a Hospital at Home Unit," the authors conclude that opioid use in the home setting did not have a negative effect on patient survival time.
"Many worry that use of opioids in end-of-life care tacitly hastens death. Reassuringly, the results of this study show that higher doses were safe in the home and linked to longer survival," says Charles F. von Gunten, MD, PhD, Editor-in-Chief of Journal of Palliative Medicine and Provost, Institute for Palliative Medicine at San Diego Hospice.
INFORMATION:
Journal of Palliative Medicine is the Official Journal of the Center to Advance Palliative Care (CAPC) and the Australian and New Zealand Society of Palliative Medicine (ANZSPM), and an Official Journal of the Hospice and Palliative Nurses Association (HPNA). JPM is a monthly, interdisciplinary journal published in print and online that reports on the clinical, educational, legal, and ethical aspects of care for seriously ill and dying patients. The Journal includes coverage of the latest developments in drug and non-drug treatments for patients with life-threatening diseases including cancer, AIDS, cardiac disease, pulmonary, neurologic, respiratory conditions, and other diseases. The Journal reports on the development of palliative care programs around the United States and the world, and on innovations in palliative care education. Tables of content and a free sample issue may be viewed online (www.liebertpub.com/jpm).
Mary Ann Liebert, Inc. (www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including AIDS Patient Care and STDs, Population Health Management, and Briefings in Palliative, Hospice, and Pain Medicine & Management, a weekly e-News Alert.. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, newsmagazines, and books is available at www.liebertpub.com
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
www.liebertpub.com
END
ELSE PRESS RELEASES FROM THIS DATE:
2010-09-09
Amsterdam, The Netherlands, September 2010
More than 7,000 psychiatrists, neurologists, psychologists and neuroscience researchers from all over the world met at the 23rd Congress of the European College of Neuropsychopharmacology (ECNP) from 28 August to 1 September 2010 in Amsterdam.
The ECNP Congress is the largest scientific meeting on mental health in Europe, and this year included 46 sessions presented by more than 150 distinguished speakers from 20 countries. In addition, three poster sessions with in total more than 750 poster presentations from scientists ...
2010-09-09
A risk may be posed, for example, by luggage left in a public place which may contain explosives or other dangerous substances. Terror attacks based on this tactic have already claimed many civilian lives. Luggage surveillance is particularly important at airports, railway stations, trade fairs, and public spaces in nationally significant infrastructure.
The aim of the SUBITO project, which is funded by the European Commission, is to improve image analysis technology in existing CCTV systems. With the help of an application developed as part of the project, cameras recognise ...
2010-09-09
Montreal, September 9th, 2010 – An investigation published in The Journal of Sexual Medicine has found that male partners who express greater support, attention and sympathy to women's chronic vulvovaginal pain may trigger more pain, but also increase sexual satisfaction in female partners.
Women who took part in the study, conducted by the University of Montreal and University of Montreal Hospital Research Centre, suffer from a condition called provoked vestibulodynia (PVD). A condition that affects 12 percent of premenopausal women, PVD can impair sexual functioning ...
2010-09-09
Behind every coincidence lies a plan - in the world of classical physics, at least. In principle, every event, including the fall of dice or the outcome of a game of roulette, can be explained in mathematical terms. Researchers at the Max Planck Institute for the Physics of Light in Erlangen have constructed a device that works on the principle of true randomness. With the help of quantum physics, their machine generates random numbers that cannot be predicted in advance. The researchers exploit the fact that measurements based on quantum physics can only produce a special ...
2010-09-09
Fresh insight into how plants slow their growth in cold weather could help scientists develop crops suited to cooler environments.
Researchers have shown for the first time that a gene – known as Spatula – limits the growth of plants in cool temperatures, possibly helping them adjust to cool conditions.
Researchers at the University of Edinburgh, who took part in the study, believe that by manipulating the gene, they could produce the opposite effect – enabling development of crops that grow well in cold climates.
Scientists studied the Spatula gene in a weed known ...
2010-09-09
One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.
Most individuals with TB recover from the initial infection and become asymptomatic, ...
2010-09-09
Essays
Title: The Prospects for Personalized Medicine
Author: Shara Yurkiewicz
Summary: Ten years after the release of a working draft of the human genome, major changes have made their way into medical practice, the marketplace, research, and policy.
Title: Personalized Medicine's Ragged Edge
Author: Leonard M. Fleck
Summary: The phrase "personalized medicine" has a built-in positive spin. But little attention has been given to some challenging issues of justice it raises. Some people will clearly benefit a lot, some people will clearly not benefit at all, and ...
2010-09-09
(WASHINGTON, September 9, 2010) – For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology. VTE, the formation of blood clots in the veins, develops in up to 20 percent of cancer patients and is one of the leading causes of death among this patient population. Patients with hematologic malignancies (blood ...
2010-09-09
EVANSTON, Ill. --- Tweet this, Ashton Kutcher, Lady Gaga and Britney Spears. Just because you have a ton of followers on Twitter doesn't necessarily mean you're among the most influential people in the Twitterverse, according to researchers from Northwestern University.
If you really want to know the most influential people tweeting on the hot topics of the day, go to pulseofthetweeters.com. The website went online in May and has been tracking the top trending topics from Twitter in real time ever since.
The website was created in the laboratory of Alok Choudhary, ...
2010-09-09
COLLEGE STATION, Sept. 9, 2010 – DNA analysis is poised to experience a significant advancement thanks to the work of a Texas A&M University chemical engineer, who has discovered a way to achieve more effective separation of DNA fragments.
Working with a widely used gelatin substance known as a hydrogel, Victor M. Ugaz, associate professor in the university's Artie McFerrin Department of Chemical Engineering, and graduate student Nan Shi have been able to determine the specific type of conditions that result in the optimum gel pore structure for separation of a wide range ...
LAST 30 PRESS RELEASES:
[Press-News.org] Opioid use to relieve pain and suffering at end of life is safe in hospital-at-home setting
According to a study in Journal of Palliative Medicine
